Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
INVO Fertility ( (IVF) ) just unveiled an announcement.
On July 17, 2025, an institutional investor exercised its Additional Investment Right to acquire 200 shares of INVO Fertility‘s Series C-2 Convertible Preferred Stock for $200,000, adjusting the conversion price post-split to $1.9953 per share. Additionally, during the company’s annual meeting, stockholders approved an amendment to increase the authorized shares of common stock from 1,388,888 to 50,000,000, reflecting a significant expansion in the company’s capital structure.
The most recent analyst rating on (IVF) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Neutral.
INVO Fertility’s financial performance indicates significant operational challenges and high leverage, which are the most significant factors affecting the score. Technical analysis shows bearish trends, further weighing down the score. Valuation concerns due to negative profitability further impact the overall assessment.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
INVO Fertility, Inc. operates in the fertility industry, focusing on providing innovative solutions for assisted reproductive technologies. The company is involved in the development and commercialization of medical devices and treatments aimed at improving fertility outcomes.
Average Trading Volume: 1,689,730
Technical Sentiment Signal: Sell
Current Market Cap: $3.21M
Learn more about IVF stock on TipRanks’ Stock Analysis page.